Monitoring the scientific literature. Systematically, missing nothing.
Growing volumes of publications, surveillance obligations: it takes method, not occasional reading.
The literature must be surveilled, not just consulted.
For pharmacovigilance and for medical affairs, systematic monitoring of the scientific literature is both an obligation and a necessity: identifying new evidence, safety signals, and relevant publications on a product or a therapeutic area. The growing volume of publications makes it impossible to do exhaustively by hand.
It takes a structured process — defined sources, search criteria, frequency, classification of results — where nothing relevant slips through and every stage is documented.
Merqurio carries out systematic literature screening with method and, where useful, AI support.
Periodic surveillance of the defined sources, with structured search criteria.
Selection and classification of relevant publications, with routing to pharmacovigilance or medical affairs.
Where useful, AI helps manage the volumes — semantic analysis, pre-selection — while keeping human oversight central.
Documentation of the process in support of surveillance obligations.
A systematic process that leaves no gaps.
AI support handles the scale while keeping you in control.
Routing to pharmacovigilance.
Monitoring of relevant new evidence.
Literature screening is worthwhile if it is systematic and connected to the processes that use its results. At Merqurio it is integrated with pharmacovigilance and medical affairs.
The structured method, AI support where it increases efficiency without reducing control, and the domain expertise of the medical direction ensure that monitoring is exhaustive and that results end up where they are needed.
